Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurotrophins.

Georg Dechant1, Harald Neumann

  • 1Neurobiochemistry, Max-Planck-Institute of Neurobiology, Am Klopferspitz 18a, 82152 Martinsried, Germany.

Advances in Experimental Medicine and Biology
|February 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Polysialic acid restrains inflammatory monocyte maturation.

Frontiers in immunology·2025
Same author

Polysialic acid restrains inflammatory monocyte maturation.

Frontiers in immunology·2025
Same author

Sialylation as a checkpoint for inflammatory and complement-related retinal diseases.

Frontiers in cellular neuroscience·2025
Same author

Neuroprotective role of sialic-acid-binding immunoglobulin-like lectin-11 in humanized transgenic mice.

Frontiers in neuroscience·2025
Same author

Decreased sialylation elicits complement-related microglia response and bipolar cell loss in the mouse retina.

Glia·2024
Same author

Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases.

Frontiers in neurology·2024
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Neurotrophins, like nerve growth factor, protect neurons from death and show potential for treating neurological disorders. Further research is needed to overcome challenges in their clinical application.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Neurotrophins, including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), are proteins known for their anti-apoptotic effects on neurons.
  • These factors target neurons affected by neurodegenerative diseases (e.g., Alzheimer's, Parkinson's) and other neurological conditions (e.g., ischemia, epilepsy, depression).

Purpose of the Study:

  • To review the role of neurotrophins in preventing neuronal death and their therapeutic potential.
  • To highlight the challenges and knowledge gaps hindering effective clinical application of neurotrophins.

Main Methods:

  • Review of existing literature on neurotrophin function in cell cultures and animal models.
  • Analysis of outcomes from early clinical trials involving neurotrophin-based therapies.

Related Experiment Videos

Main Results:

  • Cell culture and animal model studies strongly support the neuroprotective capabilities of neurotrophins.
  • Initial clinical trials yielded inconsistent results and significant side effects, indicating limitations in current therapeutic strategies.

Conclusions:

  • Neurotrophins hold promise as symptomatic treatments for various neurological and psychiatric disorders.
  • Further investigation into neurotrophin physiology and pharmacokinetics is essential for developing safe and effective therapeutic applications.